A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial

OBJECTIVE: The role of U300 glargine insulin for the inpatient management of type 2 diabetes (T2D) has not been determined. We compared the safety and efficacy of glargine U300 versus glargine U100 in noncritically ill patients with T2D. RESEARCH DESIGN AND METHODS: This prospective, open-label, ran...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Care
Autors principals: Pasquel, Francisco J., Lansang, M. Cecilia, Khowaja, Ameer, Urrutia, M. Agustina, Cardona, Saumeth, Albury, Bonnie, Galindo, Rodolfo J., Fayfman, Maya, Davis, Georgia, Migdal, Alexandra, Vellanki, Priyathama, Peng, Limin, Umpierrez, Guillermo E.
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2020
Matèries:
Emerging Therapies: Drugs and Regimens
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7411278/
https://ncbi.nlm.nih.gov/pubmed/32273271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-1940
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars